VOYA INVESTMENT MANAGEMENT LLC - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 94 filers reported holding CTI BIOPHARMA CORP in Q4 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2016$54,000
-56.8%
101,2600.0%0.00%
Q4 2015$125,000
-15.5%
101,2600.0%0.00%
Q3 2015$148,000
-24.9%
101,2600.0%0.00%
Q2 2015$197,000
-5.3%
101,260
-11.9%
0.00%
Q1 2015$208,000
-23.2%
114,9590.0%0.00%
-100.0%
Q4 2014$271,000
-2.5%
114,9590.0%0.00%0.0%
Q3 2014$278,000
-13.9%
114,9590.0%0.00%0.0%
Q2 2014$323,000114,9590.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q4 2015
NameSharesValueWeighting ↓
EAGLE ASSET MANAGEMENT INC 15,707,022$38,010,0000.11%
First Heartland Consultants, Inc. 74,624$181,0000.08%
WASHINGTON TRUST Co 410,616$994,0000.07%
Geduld E E 40,000$97,0000.07%
FIRST NEW YORK SECURITIES LLC /NY 30,562$73,960,0000.05%
Crosspoint Capital Strategies, LLC 25,000$61,0000.04%
JANE STREET GROUP, LLC 1,434,975$3,473,0000.04%
MAGEE THOMSON INVESTMENT PARTNERS LLC 21,479$51,0000.01%
TIAA CREF TRUST CO FSB/MO 296,322$717,0000.01%
Investors Capital Advisory Services 16,950$41,0000.01%
View complete list of CTI BIOPHARMA CORP shareholders